Short communication · 29 Aug 2026
Conference abstractPublished 25 Sep 2017
Peripheral blood mononuclear cells may contain a small amount of mesenchymal stem cells which express type VII collagen
Hirosaki University, Japan
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Introduction: In mutational analysis of dystrophic epidermolysis bullosa (DEB), COL7A1 mutations are analyzed using genomic DNA obtained from peripheral blood mononuclear cells (PBMCs). However, additional invasive skin biopsies are required to obtain mRNA from keratinocytes or fibroblasts for detecting the consequences of the mutations. Recently, we revealed the exact expression levels of COL7A1 mRNA in PBMCs and demonstrated that RT-PCR and direct sequencing of cDNA using mRNA obtained from PBMCs are useful, non-invasive methods that can confirm the accurate consequences of COL7A1 mutations. However, the types of cells in PBMCs that express type VII collagen remains to be elucidated. Several reports have shown that bone marrow-derived mesenchymal stem cells (MSCs) recruited to skin produce functional type VII collagen. Hence, the aim of this study is to elucidate whether MSCs circulating in peripheral blood actually express type VII collagen. Methods & Results: First, we tried to isolate MSCs from circulating PBMCs. CD105 and CD29 are the widely accepted markers of MSCs, while CD45 and CD34 are representative hematopoietic lineage markers. Flow cytometric analysis failed to detect CD45-negative and CD105-positive cells in a population of 200,000 circulating PBMCs. Subsequently, we isolated MSCs from PBMCs using human mesenchymal stem cell enrichment cocktail and cultured those cells in MSC growth medium. Immunofluorescence examinations showed that these isolated cells expressed type VII collagen and were positive for CD29 and CD105 and negative for CD45 and CD34, which is consistent with the immunological features of MSCs. These results showed that PBMCs contain a very small percentage of circulating mesenchymal stromal cells, which possibly include MSCs and those cells can express type VII collagen. Conclusion: Although the actual function of type VII collagen-expressing MSCs remains unknown, the existence of type VII collagen in PBMCs will surely be helpful for developing novel therapeutic and diagnostic methods for DEB.
Subjects
DermatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Dermatology and Dermatologic Diseases.
Conference abstract · 15 Jun 2026
Cellular Mechanisms of Skin Aging and Regenerative Dermatology: From Molecular Biology to Clinical Practice
Conference abstract · 15 Jun 2026
Innovative Approaches in Acne Management and Cosmetic Dermatology: From Molecular Mechanisms to Personalized Therapy
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Dermatology and Dermatologic Diseases
- SubjectDermatology
- BylineArticles whose byline prints “Eijiro Akasaka”
- BylineArticles whose byline prints “Hajime Nakano”
- BylineArticles whose byline prints “Daisuke Sawamura”
